Waiting for the CRISPR patent decision? Here’s what we know – STAT
STAT |
Waiting for the CRISPR patent decision? Here's what we know
STAT Investors, lawyers, patent agents, biotech executives, and scientists have been anxiously waiting for the Patent Trial and Appeal Board to decide whether foundational CRISPR-Cas9 patents awarded to the Broad Institute of Harvard and MIT beginning in … |
